PIK3CA and neoplasm: Liquid biopsy by circulating tumor DNA (ctDNA) analysis offers a promising alternative to traditional tissue biopsy methods for detecting PIK3CA mutations, thereby enhancing minimally invasive patient monitoring and treatment selection.